Testing effectiveness (Phase 2)Study completedNCT07102706
What this trial is testing
Phase I Trial of GR1803 Injection in Patients With RRMM
Who this might be right for
Multiple Myeloma (MM)
Genrix (Shanghai) Biopharmaceutical Co., Ltd. 76
Showing 20 of 0 results